Fernández MM, Rivera LFP, Toussaint CS, Roldán MR

Language: Spanish
References: 14
Page: 431-435
PDF size: 198.46 Kb.

ABSTRACT

Basal cell carcinoma (BCC) is the most common malignancy in humans. Its incidence has been increasing, since it is a tumor that derives mainly due to accumulated sun damage on the skin.
Although BCC has low mortality it can cause a significant impact on the quality of life mainly through local destruction. The definitive diagnosis is achieved through a histological study, however, both dermoscopy and confocal reflectance microscopy provide data of relevance for early clinical diagnosis. Despite the high recurrence rate in topical treatments as monotherapy, the combined treatment using topical imiquimod 5% and topical tretinoin 0.05% was found to be effective for the total resolution of superficial BCC.
We present the case of a 74-year-old female with a lesion on the posterior aspect of the trunk, with the diagnosis of superficial BCC, treated with a combination of topical imiquimod and tretinoin.

REFERENCES

1. Wu P, Epidemiology, pathogenesis, and clinical features of basal cellcarcinoma, Up To Date 2021. Disponible en: https://www-uptodate-com.pbidi.unam.mx:2443/contents/epidemiology-pathogenesisandclinical-features-of-basal-cellcarcinoma?_search=carcinoma%20basocelular&source=search_result&selectedTitle=1~150&usage_type=default&display_ rank=1#H29.

2. Baladrón A y Pérez L, Aplicación de la dermatoscopia para el diagnósticodel carcinoma basocelular en atención primaria, Formación MédicaContinuada en Atención Primaria 2016; 23(2),e23-5.

3. Ruiz González J, Guevera Gutiérrez E, Hernández Torres M, Solís LedesmaG y Tlacuilo Parra A, Risk of recurrence and new malignantcutaneous neoplasms in Mexican subjects with basal cell carcinoma,Cirugía y Cirujanos 2019; 86(5).

4. Mahatma G, Sweeney AR y Yen MT, Imiquimod for superficial basalcell carcinomas, International Ophthalmology Clinics 2020; 60(2): 3-11.

5. Peris K, Fargnoli M, Garbe C, Kaufmann R, Bastholt L, Seguin N, et al.,Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines, European Journal of Cancer 2019;118:10-34.

6. Shahriari N, Grant Kels J, Rabinovitz H, Oliviero M y Scope A, Reflectanceconfocal microscopy, Journal of the American Academy of Dermatology2021; 84(1):1-14.

7. González S, Sánchez V, González Rodríguez A, Parrado C y UllrichM, Patrones de microscopía confocal para el cáncer cutáneo no melanomay aplicaciones clínicas, Actas Dermo-Sifiliográficas 2014; 105(5):446-58.

8. Bath Hextall F, Ozolins M, Armstrong S, Colver G, Perkins W, MillerP et al., Surgical excision versus imiquimod 5% cream for nodular andsuperficial basal-cell carcinoma (sins): a multicentre, non-inferiority,randomised controlled trial, The Lancet Oncology 2014; 15(1):96-105.

9. Ariza S, Espinosa S y Naranjo M, Terapias no quirúrgicas para el carcinomabasocelular: revisión, Actas Dermo-Sifiliográficas 2017; 108(9):809-17.

10. Graells J, Ojeda R y García Cruz A, Efecto del imiquimod comparadocon la cirugía sobre el campo de cancerización en el carcinoma basocelular,Actas Dermo-Sifiliográficas 2014; 105(1): 53-9.

11. Baldwin HE, Nighland M, Kendall C, Mays DA, Grossman R y NewburgerJ, 40 years of topical tretinoin use in review, Journal of Drugs inDermatology 2013; 12(6):638-42.

12. Brenner S, Wolf R y Dascalu D, Topical tretinoin treatment in basalcell carcinoma, Journal of Dermatologic Surgery and Oncology 1993;19(3):264-6.

13. Pasquali P, Segurado-Miravalles G, Freites-Martínez A y González-RodríguezS, Cryosurgical management of basal cell carcinoma: in vivofollow-up using reflectance confocal microscopy, International Journalof Dermatology 2018; 58(2):e30-2.

14. Webber S, Wurm E, Douglas N, Lambie D, Longo C, Pellacani G ySoyer H, Effectiveness and limitations of reflectance confocal microscopyin detecting persistence of basal cell carcinomas: a preliminarystudy, Australasian Journal of Dermatology 2011; 52(3):179-85.